Free Trial
→ Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (From Weiss Ratings) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 5 of 15

Slide 5
Back to 4
Continue to 6
 
Back to 4
Continue to 6
 

Corcept Therapeutics (NASDAQ:CORT)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$143.25 (130.2% Upside)

About Corcept Therapeutics

Corcept Therapeutics logoCorcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. More about Corcept Therapeutics
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/3/2025Piper SandlerBoost Price TargetOverweight ➝ Overweight$128.00 ➝ $131.00
4/1/2025Canaccord Genuity GroupBoost Price TargetBuy ➝ Buy$130.00 ➝ $142.00
3/31/2025Truist FinancialBoost Price TargetBuy ➝ Buy$76.00 ➝ $150.00
3/31/2025HC WainwrightBoost Price TargetBuy ➝ Buy$115.00 ➝ $150.00
2/27/2025Piper SandlerBoost Price TargetOverweight ➝ Overweight$67.00 ➝ $78.00
2/27/2025HC WainwrightReiterated RatingBuy ➝ Buy$115.00 ➝ $115.00
2/7/2025HC WainwrightReiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
1/30/2025Canaccord Genuity GroupBoost Price TargetBuy ➝ Buy$78.00 ➝ $130.00
10/31/2024HC WainwrightReiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
10/18/2024Sandler O'NeillReiterated RatingBuy ➝ Buy
Slide 5
Back to 4
Continue to 6
 

More From MarketBeat
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
15 Stocks Institutional Investors Are Selling Now
Hedge funds, endowments, and other institutional investors have been selling shares of these 15 stocks in the ...
MarketBeat
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
10 Best Small Cap Stocks to Buy Now
Let's talk about small cap stocks. It's common knowledge that tilting your stock portfolio toward smaller-capi...
MarketBeat
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
The 12 Most-Hated Stocks on Wall Street
Wall Street research analysts must be the most optimistic people on earth. They give "buy" ratings to more tha...
MarketBeat